Reference Source

71288-563-85 · Liraglutide Injection · Meitheal Pharmaceuticals, Inc.

What is the status for 71288-563-85 · Liraglutide Injection · Meitheal Pharmaceuticals, Inc.?

For 71288-563-85, generic name is Liraglutide Injection; manufacturer is Meitheal Pharmaceuticals, Inc; status is Current; availability now is Available; initial posting date is 07/18/2023, recorded from its source on 2026-11-04.

"initial_posting_date": "07/18/2023", "package_ndc": "71288-563-85", "generic_name": "Liraglutide Injection", "contact_info": "844-824-8426", "availability": "Available"

— api.fda.gov, retrieved 2026-11-04

Package NDC
71288-563-85 verified
Generic name
Liraglutide Injection verified
Manufacturer
Meitheal Pharmaceuticals, Inc. verified
Status
Current verified
Availability now
Available verified
Initial posting date
07/18/2023 verified
Last update date
08/27/2026 verified
Days in shortage
1205 our reading
Dosage form
Injection verified
Therapeutic category
Endocrinology/Metabolism verified
Sourceapi.fda.gov
Verified
Review by
DatasetFDA drug shortage duration tracker

Values marked our reading are our classification of what the source says — the source does not print them in those words. The quote below is the evidence for each one; judge it yourself.

Where each value comes from

The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.

Manufacturer, Status, Last update date, Dosage form and Therapeutic category

"update_date": "08/27/2026", "therapeutic_category": [ "Endocrinology/Metabolism" ], "dosage_form": "Injection", "presentation": "Liraglutide, Injection, 6 mg/1 mL (NDC 71288-563-85)", "company_name": "Meitheal Pharmaceuticals, Inc.", "status": "Current"

— all from api.fda.gov, retrieved 2026-11-04

Source

Last verified against source: . Due for re-check by . This page as Markdown · OKF bundle · full dataset as JSON.